EXPLORING THE POTENTIAL OF CRISPR-CAS9 TECHNOLOGY IN GENE EDITING FOR DISEASE TREATMENT

Abstract

The CRISPR-Cas9 gene-editing system has revolutionized modern biotechnology by providing a precise, efficient, and versatile tool for modifying specific genetic sequences. Its applications in human therapeutics have garnered significant attention, particularly for the treatment of genetic disorders, cancer, and persistent viral infections. As a molecular tool originally derived from bacterial immune systems, CRISPR-Cas9 enables targeted genomic alterations through RNA-guided DNA cleavage and subsequent repair, offering the potential for curative interventions in previously intractable diseases.This study investigates the clinical utility of CRISPR-Cas9 across three primary domains: monogenic disease correction, cancer immunotherapy, and antiviral strategies. Using a combination of simulated data modeling and real-world clinical outcomes from recent trials, we assessed editing efficiency, off-target effects, and therapeutic success across multiple gene targets and repair mechanisms. The methodology involved comparative analysis of non-homologous end joining and homology-directed repair, alongside evaluation of immune enhancement strategies via checkpoint gene disruption and T-cell receptor engineering.The results revealed consistently high editing efficiency in corrected hematopoietic and epithelial cell models, with minimal off-target effects observed under optimized guide RNA conditions. Immunotherapy applications demonstrated significant tumor cell clearance and enhanced T-cell activity following CRISPR modification. In antiviral contexts, CRISPR was successful in targeting integrated viral genomes, indicating its potential for functional cures.In conclusion, CRISPR-Cas9 represents a transformative advancement in personalized medicine, offering curative potential for a wide range of conditions. While challenges such as ethical considerations, delivery mechanisms, and long-term safety persist, the growing body of evidence supports the responsible integration of CRISPR into clinical practice. This study contributes to the broader understanding of CRISPR’s therapeutic versatility and sets the stage for its future application in next-generation medical interventions.